Upgrade to SI Premium - Free Trial

Johnson & Johnson (JNJ) PT Raised to $250 at Stifel on Beat and Raise Performance

April 15, 2026 6:50 AM
Stifel analyst Rick Wise raised the price target on Johnson & Johnson (NYSE: JNJ) to $250.00 (from $220.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change